Giovannoni G, et al. Treatment outcomes of daclizumab in patients at high risk of transitioning to secondary progressive multiple sclerosis in DECIDE. EAN 2107, O2113.
Techniek uit gamingwereld helpt bij inschatten valrisico
mei 2019 | Bewegingsstoornissen, Neuro-vasculair